76 related articles for article (PubMed ID: 19497390)
1. Two year sublingual immunotherapy affects serum leptin.
Ciprandi G; De Amici M; Tosca M; Negrini S; Murdaca G; Marseglia GL
Int Immunopharmacol; 2009 Sep; 9(10):1244-6. PubMed ID: 19497390
[TBL] [Abstract][Full Text] [Related]
2. Adipokines and sublingual immunotherapy: preliminary report.
Ciprandi G; De Amici M; Murdaca G; Filaci G; Fenoglio D; Marseglia GL
Hum Immunol; 2009 Jan; 70(1):73-8. PubMed ID: 19028536
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin levels in patients with pollen-induced allergic rhinitis.
Ciprandi G; Filaci G; Negrini S; De Amici M; Fenoglio D; Marseglia G
Int Arch Allergy Immunol; 2009; 148(3):211-8. PubMed ID: 18849612
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta and IL-17 serum levels and specific immunotherapy.
Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
[TBL] [Abstract][Full Text] [Related]
6. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin levels depend on allergen exposure in patients with seasonal allergic rhinitis.
Ciprandi G; De Amici M; Tosca MA; Marseglia G
Immunol Invest; 2009; 38(8):681-9. PubMed ID: 19860581
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
10. Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.
Ciprandi G; De Amici M; Tosca M; Marseglia G
Int Arch Allergy Immunol; 2010; 152(1):66-70. PubMed ID: 19940507
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
12. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin levels in patients with pollen-induced allergic rhinitis.
Ciprandi G; Murdaca G; Marseglia G; Colombo BM; Quaglini S; De Amici M
Int Immunopharmacol; 2008 Jun; 8(6):945-9. PubMed ID: 18442802
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy may affect serum neopterin: preliminary findings.
Ciprandi G; De Amici M; Marseglia G; Fuchs D
Int Immunopharmacol; 2010 Nov; 10(11):1474-6. PubMed ID: 20863918
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
[TBL] [Abstract][Full Text] [Related]
17. Rush sublingual immunotherapy in Parietaria allergic patients.
D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
19. The type of sensitizing allergen can affect the evolution of respiratory allergy.
Marogna M; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
